Article | August 18, 2023

The Advantages Of Blow/Fill/Seal Processing For Vaccine Production

By Marty Reyes

Weiler (002)

Traditional vaccine production often includes an equally traditional vessel for end products: multi-dose glass vials, which have served as the standard for many drugs for decades. However, the use of glass vials creates a number of challenges for manufacturers and providers alike, which has led to recognition among regulators that advanced aseptic processing techniques, like blow/fill/seal (BFS), offer greater safety and customization for drug product manufacturing.

Multicomponent filling and sterilizing systems represent unique advantages for vaccine production. Discover how these systems can be adapted for vaccine production without incurring any product degradation, and their widespread implementation can be achieved through adaptive strategies centered on experience, scientific principles, and long-term, global strategies.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online